FAYETTEVILE, N.C. (WTVD) -- Fayetteville native John Rowell calls the FDA's approval of the first injectable treatment for HIV pre-exposure prevention, PrEP, "monumental." The FDA said the injectable ...
According to UNAIDS, in 2024, about 40.8 million people around the world were living with the human immunodeficiency virus (HIV) — a virus that can lead to acquired immunodeficiency syndrome (AIDS) if ...
Long-acting CAB+RPV is preferred by patients for ART due to reduced dosing frequency and stigma, with 89% switching after viral suppression. Studies like PILLAR and EBONI confirm the effectiveness and ...
ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, VH184 and VH499.
Tuko News on MSN
Kawangare delivery man becomes first person to use long-acting HIV prevention injection, Lenacapavir
Samson Mutua, 27, is the first Kenyan to receive Lenacapavir, a long-acting HIV prevention injection, marking a significant ...
(RTTNews) - Gilead Sciences Inc. (GILD) announced that the U.S. Food and Drug Administration has approved Yeztugo (lenacapavir)-the company's injectable HIV-1 capsid inhibitor-as pre-exposure ...
Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A once-daily pill named PrEP, or pre-exposure prophylaxis, has been a stalwart ...
Uganda has received its first consignment of Lenacapavir, a long-acting HIV prevention injection administered twice a year, ...
Legit.ng on MSN
WHO mentions injection that can prevent Nigerians from getting HIV, doctor release price
WHO issued guidelines on July 14, 2025, recommending twice-yearly lenacapavir injections for HIV prevention, raising urgent questions for Nigeria’s response.
Gilead Sciences is coming off a milestone year that saw the start of the much-anticipated launch of the world’s first twice-yearly injectable HIV pre-exposure prophylaxis (PrEP) medicine Yeztugo ...
Add Yahoo as a preferred source to see more of our stories on Google. a group of fit men in blue and white outfits promote national prep day Today is the first National PrEP Day — a new annual event ...
Kenya has received 21,000 doses of the long-acting HIV prevention injection Lenacapavir, with rollout set to begin in March.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results